Princeton Global Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $172K | Buy |
2,457
+400
| +19% | +$28K | 0.03% | 197 |
|
|
2025
Q1 | $151K | Sell |
2,057
-560
| -21% | -$41.2K | 0.03% | 201 |
|
|
2024
Q4 | $171K | Sell |
2,617
-1,176
| -31% | -$77.1K | 0.03% | 200 |
|
|
2024
Q3 | $295K | Sell |
3,793
-155
| -4% | -$12.1K | 0.06% | 159 |
|
|
2024
Q2 | $308K | Buy |
3,948
+411
| +12% | +$32.1K | 0.07% | 142 |
|
|
2024
Q1 | $240K | Sell |
3,537
-1,005
| -22% | -$68.1K | 0.06% | 149 |
|
|
2023
Q4 | $306K | Hold |
4,542
| – | – | 0.08% | 135 |
|
|
2023
Q3 | $308K | Buy |
4,542
+1,983
| +77% | +$134K | 0.09% | 124 |
|
|
2023
Q2 | $183K | Sell |
2,559
-2,200
| -46% | -$157K | 0.05% | 168 |
|
|
2023
Q1 | $330K | Buy |
4,759
+3
| +0.1% | +$208 | 0.1% | 132 |
|
|
2022
Q4 | $322K | Hold |
4,756
| – | – | 0.1% | 124 |
|
|
2022
Q3 | $261K | Buy |
4,756
+2
| +0% | +$110 | 0.09% | 133 |
|
|
2022
Q2 | $314K | Sell |
4,754
-500
| -10% | -$33K | 0.1% | 130 |
|
|
2022
Q1 | $349K | Sell |
5,254
-1,197
| -19% | -$79.5K | 0.1% | 131 |
|
|
2021
Q4 | $376K | Sell |
6,451
-126
| -2% | -$7.34K | 0.11% | 140 |
|
|
2021
Q3 | $395K | Hold |
6,577
| – | – | 0.12% | 135 |
|
|
2021
Q2 | $394K | Sell |
6,577
-2,400
| -27% | -$144K | 0.12% | 135 |
|
|
2021
Q1 | $446K | Buy |
8,977
+1,300
| +17% | +$64.6K | 0.14% | 126 |
|
|
2020
Q4 | $384K | Sell |
7,677
-300
| -4% | -$15K | 0.13% | 128 |
|
|
2020
Q3 | $437K | Buy |
7,977
+791
| +11% | +$43.3K | 0.18% | 117 |
|
|
2020
Q2 | $380K | Buy |
7,186
+6,875
| +2,211% | +$364K | 0.12% | 145 |
|
|
2020
Q1 | $14K | Hold |
311
| – | – | 0.01% | 344 |
|
|
2019
Q4 | $16 | Buy |
+311
| New | +$16 | 0.01% | 359 |
|